Salesforce: You Might Wish You Bought More Now

Salesforce (CRM) stock has significantly underperformed software peers, trading at a valuation of 13.4x forward EBITDA, well below its historical average, as the market remains skeptical about its ability to maintain its economic moat against disruption from rapidly growing Agentic AI companies. While Salesforce has surpassed $1 billion in AI-related ARR, investors are closely scrutinizing its execution in integrating Agentic AI ("Agentforce") and fending off pure-play AI firms like OpenAI. The article maintains a "Buy" rating, arguing that much of this uncertainty is already priced into CRM's current valuation, presenting a timely opportunity.

Analysis

Salesforce (CRM) is experiencing a significant valuation disconnect from its software peers (IGV), trading at a 13.4x forward EBITDA multiple, which represents a level two standard deviations below its 10-year historical average. This depressed valuation reflects deep market skepticism regarding the company's ability to defend its economic moat against the disruptive potential of Agentic AI. While competitors like Microsoft (MSFT), Oracle (ORCL), and Palantir (PLTR) have seen their valuations expand on AI-driven narratives, Salesforce's stock has underperformed. The market appears concerned that Salesforce's strategic response, centered on its 'Agentforce' initiative, may not be scaling quickly enough. The company has surpassed $1 billion in Annual Recurring Revenue (ARR) from its Data Cloud and AI products, but this is a small fraction of its projected FY2026 revenue of over $41.2 billion, raising questions about its competitive velocity against rapidly growing pure-play AI firms. This investor reticence persists despite the company's shift to a profitable growth model and a strong net cash balance sheet, indicating that the primary focus is now on its execution and ability to maintain platform dominance in a shifting technological landscape.

Key Decisions for Investors

• Given that Salesforce's valuation reflects significant priced-in pessimism, investors with a higher risk tolerance may consider the current stock price a contrarian opportunity, predicated on management successfully executing its AI strategy.
• Monitor the growth rate of Salesforce's AI and Data Cloud ARR in subsequent quarters as the primary metric for gauging the success of its 'Agentforce' initiative and its ability to compete with AI-native firms.
• Investors should weigh the execution risk inherent in Salesforce's AI transition against the potentially stretched valuations of outperforming software peers that have already heavily priced in AI-related growth.
• Scrutinize management's go-to-market strategy and sales cadence for signs of accelerated AI integration, as the market is poised to re-rate the stock only upon tangible proof of its ability to capitalize on the Agentic AI shift.